Baas P - Search Results

1

Distribution of 99mTc colloid in the thoracic cavity of patients with malignant pleural effusions.

Baas P, Neijens VH, Olmos RA, Hoefnagel CA. Baas P, et al. Lung Cancer. 1997 Jul;17(2-3):239-47. doi: 10.1016/s0169-5002(97)00031-7. Lung Cancer. 1997. PMID: 9237159

2

Actinomycosis, a sheep in wolves' clothes.

Neijens V, van Heerde P, van der Heijden A, Baas P. Neijens V, et al. Among authors: baas p. Lung Cancer. 1996 Aug;15(1):131-5. doi: 10.1016/0169-5002(96)00578-8. Lung Cancer. 1996. PMID: 8865131

3

Radiation pneumonitis imaged with indium-111-pentetreotide.

Valdés Olmos RA, van Zandwijk N, Boersma LJ, Hoefnagel CA, Baas P, Baars JB, Muller SH, Lebesque JV. Valdés Olmos RA, et al. Among authors: baas p. J Nucl Med. 1996 Apr;37(4):584-8. J Nucl Med. 1996. PMID: 8691245 Free article.

4

Thalidomide in patients with malignant pleural mesothelioma.

Baas P, Boogerd W, Dalesio O, Haringhuizen A, Custers F, van Zandwijk N. Baas P, et al. Lung Cancer. 2005 May;48(2):291-6. doi: 10.1016/j.lungcan.2004.10.005. Epub 2004 Dec 15. Lung Cancer. 2005. PMID: 15829331 Clinical Trial.

5

Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.

Baas P, Daumont MJ, Lacoin L, Penrod JR, Carroll R, Venkatesan S, Ubhi H, Calleja A, Snee M. Baas P, et al. Lung Cancer. 2021 Dec;162:185-193. doi: 10.1016/j.lungcan.2021.11.001. Epub 2021 Nov 10. Lung Cancer. 2021. PMID: 34823894 Free article.

6

Optimising survival in malignant mesothelioma.

Baas P. Baas P. Lung Cancer. 2007 Aug;57 Suppl 2:S24-9. doi: 10.1016/S0169-5002(07)70424-5. Lung Cancer. 2007. PMID: 17686442 Review.

7

Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study.

Buikhuisen WA, Qayyum F, Armato SG 3rd, Baas P. Buikhuisen WA, et al. Among authors: baas p. Lung Cancer. 2019 Dec;138:139-140. doi: 10.1016/j.lungcan.2019.10.027. Epub 2019 Nov 2. Lung Cancer. 2019. PMID: 31733933 No abstract available.

8

Non-invasive diagnosis of pleural malignancies: the role of tumour markers.

van den Heuvel MM, Korse CM, Bonfrer JM, Baas P. van den Heuvel MM, et al. Among authors: baas p. Lung Cancer. 2008 Mar;59(3):350-4. doi: 10.1016/j.lungcan.2007.08.030. Epub 2007 Oct 22. Lung Cancer. 2008. PMID: 17933420

9

Limited efficacy of imatinib mesylate in malignant mesothelioma: a phase II trial.

Mathy A, Baas P, Dalesio O, van Zandwijk N. Mathy A, et al. Among authors: baas p. Lung Cancer. 2005 Oct;50(1):83-6. doi: 10.1016/j.lungcan.2005.04.010. Lung Cancer. 2005. PMID: 15951053 Clinical Trial.

10

Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma.

Schouwink H, Korse CM, Bonfrer JM, Hart AA, Baas P. Schouwink H, et al. Among authors: baas p. Lung Cancer. 1999 Jul;25(1):25-32. doi: 10.1016/s0169-5002(99)00044-6. Lung Cancer. 1999. PMID: 10466859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters